Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
The group was recently asked to provide input on a new set of recommendations for image-guided biopsies of suspicious breast lesions—offering providers clarity on key clinical scenarios.
Published Friday in JAMA, scientists recently explored a risk-based mammography tactic that tailors regular imaging regimens to each individual’s danger of developing the disease.
In some cases, it may actually be more beneficial for this group of women to forego the extra scans, as they can lead to additional testing, costs and potentially delays in care.
Between 20% to 24% of all breast cancers diagnosed during a decade-long period were found in women between the ages of 18 to 49, according to research presented at RSNA 2025.
This image gallery shows what the various clinical presentations associated with the COVID-19 virus that have been documented during the coronavirus pandemic.
The FDA’s Center for Devices and Radiological Health (CDRH) has updated the status of two previously disaccredited mammography operations, rehabilitating the reputation of one while showing the other in limbo.
Since 2006, the FDA has recommended MRI screenings as a way to detect asymptomatic breast implant ruptures—but many patients seem unaware of or are actively ignoring the guidance.
Women who skipped screening due to financial concerns outnumbered those who were not screened due to logistical issues such as scheduling and transportation conflicts, new survey data reveals.
Experts found that although abbreviated protocols increased the amount of possible scans per hour from 4.7 to 18.8, non-scanning time rose from 50% to 74%.
In countries with low to middling gross national incomes, screening mammography appears to be a cost-effective means of minimizing breast cancer’s economic costs and public-health burdens at the population level. However …